Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients

Launched by KHYBER TEACHING HOSPITAL · May 19, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different treatments for people with localized stable non-segmental vitiligo, a skin condition that causes loss of pigment and results in white patches. The researchers want to compare the effects of needling and microneedling, both used with a type of light therapy called narrowband UVB, to see which method helps restore skin color better.

To participate in the trial, you should be between 15 and 60 years old and have had vitiligo for over a year. However, if you have a history of keloids (thick, raised scars), bleeding disorders, or any infections at the treatment site, you won't be eligible. If chosen to take part, you can expect to receive one of the two treatments and then undergo light therapy, with the hope of seeing improvement in your skin color. This trial is currently recruiting participants, so it’s a good time to consider joining if you meet the criteria!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Both male and female
• • Age 15-60 years
• • Patients having vitiligo for more than 1 year
• Exclusion Criteria:
• • Patients with tendency of keloid formation or hypertrophic scarring
• • Patients with any bleeding disorder, coagulation defect or using anti platelets
• • Any local infection at the treatment site
• • Patients who had received systemic therapy in last 6 months